Pharmacodynamic Considerations with Recombinant Human Insulin-Like Growth Factor-I in Children

Publisher： Karger

E-ISSN： 1663-2826|63|5|220-227

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.63, Iss.5, 2005-07, pp. : 220-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adult and Near-Adult Height in Patients with Severe Insulin-Like Growth Factor-I Deficiency after Long-Term Therapy with Recombinant Human Insulin-Like Growth Factor-I

By  

Hormone Research in Paediatrics, Vol. 80, Iss. 1, 2013-07 ,pp. : 47-56

Karger

Access to resources Recommend Favorite

Defining Insulin-Like Growth Factor-I Deficiency

By  

Hormone Research in Paediatrics, Vol. 65, Iss. 1, 2006-03 ,pp. : 9-14

Karger

Access to resources Recommend Favorite

Insulin-Like Growth Factor-I Treatment in Primary Growth Hormone Insensitivity: Effect of Recombinant Human IGF-I (rhIGF-I) and rhIGF-I/rhIGF-Binding Protein-3 Complex

By  

Hormone Research in Paediatrics, Vol. 73, Iss. 2, 2010-02 ,pp. : 140-147

Karger

Access to resources Recommend Favorite

Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency

By  

Hormone Research in Paediatrics, Vol. 86, Iss. 6, 2016-11 ,pp. : 361-397

Karger

Access to resources Recommend Favorite

Recombinant Human Insulin-Like Growth Factor I (IGF-I): Risks and Benefits of Normalizing Blood IGF-I Concentrations

By  

Hormone Research in Paediatrics, Vol. 62, Iss. 1, 2005-03 ,pp. : 93-100

Karger

Access to resources Recommend Favorite